Metformin in Gestational Diabetes: follow-up of mothers and offspring: body composition, insulin resistance, development

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/508061

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Children born to women with gestational diabetes are at increased risk of later obesity and diabetes. This study will help to assess if giving such women during their pregnancy the cheap oral diabetes drug metformin rather than insulin injections can safely reduce this risk, measuring growth, fatness and blood glucose-insulin in the children at 2 and 5 years of age, as well as assessing the mothers. If so, such treatment might help to reduce the worldwide burden of disease related to obesity.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2014

Funding Scheme: NHMRC Project Grants

Funding Amount: $630,142.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Paediatrics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Body composition and growth | Gestational Diabetes | Insulin resistance | Metformin | carbohydrate metabolism | child health | development | fetal programming of adult disease | long-term outcome

Related Links